RZLT ▲ +10.1% - Rezolute, Inc.
$RZLT - Rezolute Announces Positive Results from the Phase 3 upLIFT Study in Tumor Hyperinsulinism
13-NOV-2026 06:18 AM ET
Share this post
More filings for $RZLT
RZLT ▲ +10.1% - Rezolute, Inc.Nov 13, 2026RZLT ▼ -8.1% - Rezolute, Inc.Nov 5, 2026RZLT ▼ -0.8% - Rezolute, Inc.Nov 2, 2026RZLT - Rezolute, Inc. - SEC Filing Update (28-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 28, 2026RZLT ▼ -8.2% - Rezolute, Inc.Oct 14, 2026RZLT ▼ -1.2% - Rezolute, Inc.Oct 5, 2026
View full $RZLT filing history →💬 Comments
Loading comments…
Leave a comment